We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+23.95%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$395M
AUM Growth
-$21.2M
Cap. Flow
-$77.4M
Cap. Flow %
-19.6%
Top 10 Hldgs %
20.23%
Holding
152
New
37
Increased
23
Reduced
52
Closed
36

Top Sells

Rank Stock Value
1
CRDO icon
Credo Technology Group
CRDO
+$7.79M
2
FORM icon
FormFactor
FORM
+$7.6M
3
WFRD icon
Weatherford International
WFRD
+$6.99M
4
CAMT icon
Camtek
CAMT
+$5.81M
5
ARHS icon
Arhaus
ARHS
+$5.4M

Sector Composition

Rank Sector Weight
1 Industrials 26.84%
2 Technology 24.92%
3 Healthcare 23.4%
4 Consumer Discretionary 13.64%
5 Financials 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLLI icon
26
Ollie's Bargain Outlet
OLLI
$4.74B
$4.98M 1.26%
51,280
-42,145
-45% -$4.06M
LNTH icon
27
Lantheus
LNTH
$6.63B
$4.91M 1.24%
44,740
-33,135
-43% -$3.44M
PRCT icon
28
Procept Biorobotics
PRCT
$1.1B
$4.88M 1.24%
60,965
-38,275
-39% -$2.72M
TNDM icon
29
Tandem Diabetes Care
TNDM
$1.38B
$4.87M 1.23%
114,925
-43,335
-27% -$1.84M
SMTC icon
30
Semtech
SMTC
$11.3B
$4.75M 1.2%
104,065
+39,110
+60% +$1.44M
ADMA icon
31
ADMA Biologics
ADMA
$2.15B
$4.7M 1.19%
+235,035
New +$3.65M
BTSG icon
32
BrightSpring Health Services
BTSG
$12.5B
$4.66M 1.18%
+317,345
New +$3.98M
ULS icon
33
UL Solutions
ULS
$16B
$4.58M 1.16%
92,930
-20,685
-18% -$1.01M
COHR icon
34
Coherent
COHR
$64.2B
$4.57M 1.16%
51,445
-26,055
-34% -$1.95M
DY icon
35
Dycom Industries
DY
$12.3B
$4.44M 1.13%
+22,550
New +$4.07M
CSTL icon
36
Castle Biosciences
CSTL
$929M
$4.41M 1.12%
154,710
+58,160
+60% +$1.48M
TMDX icon
37
Transmedics
TMDX
$2.65B
$4.27M 1.08%
27,175
-25,775
-49% -$3.97M
PACS icon
38
PACS Group
PACS
$7.23B
$4.26M 1.08%
+106,565
New +$3.87M
ITCI
39
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.25M 1.08%
58,115
-24,760
-30% -$1.86M
VRNS icon
40
Varonis Systems
VRNS
$4.98B
$4.2M 1.06%
74,305
+10,820
+17% +$569K
FLR icon
41
Fluor
FLR
$7.2B
$4M 1.01%
83,805
-15,510
-16% -$731K
PCVX icon
42
Vaxcyte
PCVX
$8.07B
$3.72M 0.94%
32,515
+13,175
+68% +$1.19M
TREE icon
43
LendingTree
TREE
$475M
$3.65M 0.92%
+62,910
New +$3.25M
WAL icon
44
Western Alliance Bancorporation
WAL
$9.05B
$3.61M 0.91%
+41,760
New +$3.21M
KNF icon
45
Knife River
KNF
$3.85B
$3.59M 0.91%
40,185
-6,570
-14% -$513K
SG icon
46
Sweetgreen
SG
$725M
$3.55M 0.9%
100,205
-47,595
-32% -$1.45M
SITM icon
47
SiTime
SITM
$16.3B
$3.53M 0.89%
20,585
-11,650
-36% -$1.67M
PAR icon
48
PAR Technology
PAR
$719M
$3.52M 0.89%
+67,595
New +$3.51M
FIVE icon
49
Five Below
FIVE
$12.4B
$3.45M 0.87%
+39,105
New +$3.29M
RXST icon
50
RxSight
RXST
$260M
$3.45M 0.87%
69,840
-25,380
-27% -$1.3M

Similar funds

Lisanti Capital Growth's Q3 2024 Portfolio in Review

As of Q3 2024, Lisanti Capital Growth held 152 positions worth $395M, down 5.1% from $416M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lisanti Capital Growth withdrew a net $77.4M in Q3 2024, closing 36 positions and reducing 52 holdings. Its most notable exit was Credo Technology Group, an estimated $7.79M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Lisanti Capital Growth opened a new position in Zeta Global worth $9.52M.

  • Lisanti Capital Growth's largest Q3 2024 buy was Zeta Global: 319,110 shares worth $9.52M.
  • Lisanti Capital Growth added most to Kratos Defense & Security Solutions in Q3 2024, an estimated $3.64M increase.
  • Lisanti Capital Growth's biggest Q3 2024 reduction was Applied Industrial Technologies, cutting an estimated $4.29M.
  • Lisanti Capital Growth fully exited Credo Technology Group in Q3 2024, selling an estimated $7.79M.
  • Lisanti Capital Growth's ten largest holdings make up 20% of its $395M portfolio in Q3 2024.
  • Lisanti Capital Growth opened 37 new positions and closed 36 in Q3 2024.
  • Lisanti Capital Growth's portfolio value fell 5.1% quarter-over-quarter to $395M.

Based on Lisanti Capital Growth's 13F filing for Q3 2024, filed 4 Nov 2024.